Page last updated: 2024-10-30

nordefrin and Shock

nordefrin has been researched along with Shock in 1 studies

Nordefrin: A norepinephrine derivative used as a vasoconstrictor agent.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research Excerpts

ExcerptRelevanceReference
"Circulatory failure during brain death organ donor resuscitation is a problem that compromises recovery of organs."2.79Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study. ( Bleichner, JP; Cook, F; Dequin, PF; Dube, L; Escaravage, L; Lefèvre, LM; Menguy, E; Mertes, PM; Pichon, N; Pierrot, M; Pinsard, M; Ragot, S; Vignon, P; Zitouni, S, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pinsard, M1
Ragot, S1
Mertes, PM1
Bleichner, JP1
Zitouni, S1
Cook, F1
Pierrot, M1
Dube, L1
Menguy, E1
Lefèvre, LM1
Escaravage, L1
Dequin, PF1
Vignon, P1
Pichon, N1

Trials

1 trial available for nordefrin and Shock

ArticleYear
Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study.
    Critical care (London, England), 2014, Jul-23, Volume: 18, Issue:4

    Topics: Aged; Anti-Inflammatory Agents; Brain Death; Female; France; Hemodynamics; Humans; Hydrocortisone; K

2014